热门资讯> 正文
Entera Bio GAAP每股收益为-0.05美元，击败0.01美元
2024-05-11 04:36
- Entera Bio press release (NASDAQ:ENTX): Q1 GAAP EPS of -$0.05 beats by $0.01.
- As of March 31, 2024, Entera had cash and cash equivalents of $9.2 million. The Company expects that its existing cash resources are sufficient to meet its projected operating requirements into the third quarter of 2025, which includes the capital required to fund our ongoing operations, including the completion of the Phase 1 PK study related to our new generation platform and the GLP-2/OXM collaborative research with OPKO.
More on Entera Bio
- Entera Bio GAAP EPS of -$0.31 beats by $0.01
- Seeking Alpha’s Quant Rating on Entera Bio
- Historical earnings data for Entera Bio
- Financial information for Entera Bio
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
